entertainment -WSS

entertainment

author：Wikipedia 2025-09-27 21:54:41 - browse：5572

The Food and Drug Administration on Friday approved a new, rapid-acting medicine made by Sage Therapeutics to treat postpartum depression, the first oral treatment for the condition. But the agency denied the company’s application for an indication for major depression, a much larger potential market.

The drug, which will be sold under the brand name Zurzuvae, is not meant to be taken chronically. Patients take it orally for 14 days. In two clinical trials, the drug was found to significantly improve depressive symptoms more than a placebo. The effect was maintained for four weeks after treatment.

“Maternal mental health has been sidelined for far too long, but today’s approval of Zurzuvae helps to change that. Women have been waiting for an oral medicine that can specifically and rapidly improve the symptoms of PPD and we are proud to be able to deliver that,” said Barry Greene, Sage’s CEO, in a press release.

Unlock this article by subscribing to STAT+ and enjoy your first 30 days free!

GET STARTED Log In

Previous article： Bright Health sells Medicare Advantage business to Molina
Next article： An Ebola outbreak presents a new mystery involving children

WSS

Sage's campaign to raise awareness of postpartum depression hits a nerve

'Of course' Trump lost the 2020 election, DeSantis says after years of hedging

Ohioans vote in high

Ohioans vote in high

Discs beat pads, tampons for heavy menstrual flow, new study shows

Sage's campaign to raise awareness of postpartum depression hits a nerve

Wikipedia

entertainment

focus

After affirmative action ruling, medical educators look to 'holistic review'

Hospitals use virtual reality to design more inclusive rooms for kids

Peter Hotez and the public health issue of online harassment

Astronauts get first look at the spacecraft that will fly them around the moon

Psychedelics group wrestles with new pharma identity

Choosing scientific sides in the fight against Alzheimer's

Medicare proposal to cover medical devices draws a mixed reaction

Former Georgia lieutenant governor says he received grand jury subpoena

Malaria cases in Florida and Texas: Here’s what you need to know

In venture capital firm's success, lessons for turning crisis into profit

hotspot

‘The Bear’ and hospitality in hospitals

Sage's campaign to raise awareness of postpartum depression hits a nerve

Wegovy cuts risk of cardiovascular events by 20%, study finds

More regulation could be coming for drug ads

‘The Bear’ and hospitality in hospitals

NYC struggling to keep up with demand of supporting asylum seekers, Mayor Adams says

hotspot

hotspot

leisure time

focus